The relevant disclosure is attached

Fortis Healthcare Limited Tower-A, Unitech Business Park, Block-F, South City 1, Sector – 41, Gurgaon, Haryana – 122 001 (India) Tel : 0124 492 1033 Fax : 0124 492 1041 Emergency : 105010 Email : secretarial@fortishealthcare.com Website : www.fortishealthcare.com FHL/SEC/2026-27 November 5, 2026 The National Stock Exchange of India Ltd. BSE Limited Scrip Symbol: FORTIS Scrip Code: 532843 Sub: Outcome of the Board Meeting under Regulation 30, 33 and 52 of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 Dear Madam/Sir, Pursuant to the provisions of Regulation 30, 33 and 52 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. November 5, 2026 have, inter-alia, considered and approved Un-audited (Standalone & Consolidated) financial results of the Company for the quarter and half year ended September 30, 2026. Accordingly, please find enclosed herewith Un-Audited (Standalone and Consolidated) Financial Results of the Company along with Limited Review Report given by the Statutory Auditor of the Company for the quarter and half year ended on September 30, 2026. Further, Certificate with respect to the compliance of Financial Covenants, in accordance with the applicable regulations or circulars, issued by the Statutory Auditors is also enclosed along with the financial results. The Board Meeting commenced at 11:45 AM IST and concluded at 06:05 PM IST. This is for your information and record. Thanking You, Yours Sincerely, For Fortis Healthcare Limited Satyendra Chauhan Company Secretary & Compliance Officer M. No. A14783 Encl. : As stated above FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062 Tel : 0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933 B S R & Co. LLP Building No. 10, 12th Floor, Tower-C DLF Cyber City, Phase - II Chartered Accountants Gurugram - 122 002, India Tel: +91 124 719 1000 Fax: +91 124 235 8613 Limited Review Report on unaudited standalone financial results of Fortis Healthcare Limited for the quarter ended 330 September 2026 and year to date results for the period from 01 April 2026 to 30 September 2026 pursuant to Regulation 33 and Regulation 52(4) read with Regulation 63 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Fortis Healthcare Limited 1. We have reviewed the accompanying Statement of unaudited standalone financial results of Fortis Healthcare Limited (hereinafter referred to as "the Company") for the quarter ended 30 September 2026 and year to dale results for the period from 01 April 2026 to 30 September 2026 ("the Statement"). 2. This Statement, which is the responsibility of the Company's management and approved by its Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in compliance with Regulation 33 and Regulation 52(4) read with Regulation 63 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations"). Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accorda ce with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants oflndia. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 and Regulation 52(4) read with Regulation 63 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. 5. We draw attention to the following notes in the Statement: a. Note 9 and IO of the Statement which deal with various matters including the ongoing investigation by Serious Fraud Investigation Office ("SFIO") on Fortis Healthcare Limited and its subsidiaries ("the Group") regarding alleged improper transactions and non­ compliances with laws and regulations including Companies Act, 2013 (including matters relating to remuneration paid to managerial personnel). These transactions and non­ compliances relate to or originated prior to take over of control by reconstituted board of directors in the year ended 31 March 2018. As mentioned in the Note, the Group has been submitting information required by SFIO and is also cooperating in the regulatory investigations. Registered Office: 8SR&Co. [a partnership firm with Registration No, BA61223) converted into8 SR&Co. ttP {a Limited 14th Floor, Central g Wing and North C Wing, Nesto fr Pk 4, NescoCente, Liability Partnership with ttP Registration No AAB-8181) with effect from October 14, 2013 Western Express Highway, Goregaon (East), Mumbai - 400063 Page 1 of 2 B S R & Co. LLP Limited Review Report (Continued) Fortis Healthcare Limited As explained in the said Note, the Group had recorded significant adjustments/ provisions in its books of account during the year ended 31 March 2018. The Company has launched legal proceedings and has also filed a complaint with the Economic Offences Wing('EOW) against erstwhile promoters and their related entities based on the findings of the investigation conducted by the Group. Further, based on management's detailed analysis and consultation with external legal counsel, a further provision has been made and recognised in the year ended 31 March 2021 for any contingency that may arise from the aforesaid issues. As per the management, any further additional impact, to the extent it can be reliably estimated as at present, is not expected to be material. b. Note 7A of the Statement, which describes in detail the order dated 22 September 2022 of the Hon'ble Supreme Court whereby it had directed the Hon'ble High Court of Delhi, inter alia, that it may also consider issuing appropriate process and appointing forensic auditor(s) to analyse the transactions entered into between the Company and RHT Health Trust and other related transactions. Subsequently, the Hon'ble High Court of Delhi, via order dated 31 August 2026, ordered the appointment of a forensic auditor to examine such transactions as mentioned in the note. Our conclusion is not modified in respect of the above matters. For BS R & Co. LLP Chartered Accountants Firm's Registration No.: 101248W/W-100022 Rakesh Dewan Partner Gurugram Membership No.: 092212 05 November 2026 UDIN: 260922 I 2OQZCVZ4667 Page 2 of 2 FORTIS HEALTHCARE LIMITED CIN: L85110PB1996PLC045933 Fortis Hospital, Sector 62 Phase - VIII, Mohali - 160062 STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED SEPTEMBER 30, 2026 (Rupees in lacs) Particulars Standalone Quar [Showing first 8,000 characters — download PDF for full document]